Low acid uric in primary prophylaxis: Worthy?

International Journal of Cardiology

Volumn 215, Issue , 2016, Pages 223-226

  Aloia, Elio ^a   Sciaccaluga, Carlotta ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Cardiovascular disease and uric acid; Implications of lowering serum uric acid levels in cardiovascular disease

Indexed keywords

ALLOPURINOL; OXIPURINOL; PLACEBO; URIC ACID; XANTHINE OXIDASE;

ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DRUG MEGADOSE; ENDOTHELIAL DYSFUNCTION; ESSENTIAL HYPERTENSION; GOUT; HEART FAILURE; HUMAN; HYPERURICEMIA; ISCHEMIC HEART DISEASE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIMARY PREVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; URIC ACID BLOOD LEVEL; BLOOD; CARDIOVASCULAR DISEASES; EARLY DIAGNOSIS; METABOLISM; RISK FACTOR; TREATMENT FAILURE;

ALLOPURINOL; CARDIOVASCULAR DISEASES; EARLY DIAGNOSIS; HUMANS; OXYPURINOL; PRIMARY PREVENTION; RISK FACTORS; TREATMENT FAILURE; URIC ACID;

EID: 84964378647     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.04.065     Document Type: Review

References (68)

1. Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS): National Health and Nutrition Examination Survey Data 1999-2004 US Department of Health and Human Services, Centers for Disease Control and Prevention Hyattsville, MD (Available at: http://www.cdc.gov/nchs/about/major/nhanes/datalink.htm. Accessed September 2006)
2. S. Nguyen, H.K. Choi, R.H. Lustig, and C.Y. Hsu Sugar-Sweetened Beverages, Serum Uric Acid, and Blood Pressure in Adolescents J.Pediatr. 154 6 Jun 2009 807 813
3. R.J. Johnson, M.S. Segal, Y. Sautin, and et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease Am. J. Clin. Nutr. 86 2007 899 906
4. G.K. Glantzounis, E.C. Tsimoyiannis, A.M. Kappas, and D.A. Galaris Uric acid and oxidative stress. Curr Pharm Des 2005;11:4145 - 51. [2] Stocker R, Keaney Jr JF. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004;84:1381 - 478. [3] Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis Proc. Natl. Acad. Sci. U. S. A. 78 1981 (6858-62)
5. D. Giesecke, and W. Tiemeyer Defect of uric acid uptake in Dalmatian dog liver Experientia 40 1984 1415 1416
6. G. Lippi, M. Montagnana, M. Franchini, E.J. Favaloro, and G. Targher The paradoxical relationship between serum uric acid and cardiovascular disease Vols. 392(1-2) Jun 2008
7. Z. Soltani, K. Rasheed, D.R. Kapusta, and E. Reisin Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Curr. Hypertens. Rep. 15 2013 175 181
8. M. Kanbay, M. Segal, B. Afsar, D.H. Kang, B. Rodriguez-Iturbe, and R.J. Johnson The role of uric acid in the pathogenesis of human cardiovascular disease Heart 99 2013 759 766
9. H.K. Choi, and G. Curhan Independent impact of gout on mortality and risk for coronary heart disease Circulation 116 2007 894 900
10. M.J. Bos, P.J. Koudstaal, A. Hofman, J.C. Witteman, and M.M. Breteler Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam Study Stroke 37 2006 1503 1507
11. J.G. Wheeler, K.D. Juzwishin, G. Eiriksdottir, V. Gudnason, and J. Danesh Serum uric acid and coronary heart disease in 9458 incident cases and 155,084 controls: prospective study and meta-analysis PLoS Med. 2 2005 e76
12. E. Krishnan, J.F. Baker, D.E. Furst, and H.R. Schumacher Gout and the risk of acute myocardial infarction Arthritis Rheum. 54 2006 2688 2696
13. M.A. De Vera, M.M. Rahman, V. Bhole, J.A. Kopec, and H.K. Choi Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study Ann. Rheum. Dis. 69 2010 1162 1164
14. S.Y. Kim, J.P. Guevara, K.M. Kim, and et al. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis Arthritis Care Res. 62 2010 170e80
15. Iwashima Y, T. Horio, K. Kamide, H. Rakugi, T. Ogihara, and Y. Kawano Uric acid, left ventricular mass index, and risk of cardiovascular disease in essential hypertension Hypertension 47 2 Feb 2006 195 202
16. Zambon S. Zanoni, G. Romanato, and et al. Metabolic syndrome and all-cause and cardiovascular mortality in an Italian elderly population: the Progetto Veneto Anziani (Pro.V.A.) Study Care 32 1 Jan 2009 (153-9)
17. A. Zurlo, N. Veronese, V. Giantin, and et al. High Serum Uric Acid Levels Increase the Risk of Metabolic Syndrome in Elderly Women: the Pro.V.A Study Nutr. Metab. Cardiovasc. Dis Oct 24 2015 (pii: S0939-4753(15)00221-5)
18. Y. Sato, E. Yamamoto, T. Sawa, K. Toda, T. Hara, T. Iwasaki, H. Fujiwara, and Y. Takatsu High-sensitivity cardiac troponin T in essential hypertension J. Cardiol. 58 2011 226 231
19. P.C. Grayson, S.Y. Kim, M. LaValley, and et al. Hyperuricemia and incident hypertension: a systematic review and meta-analysis Arthritis Care Res. 63 2011 102e10
20. D.I. Feig, D.H. Kang, and R.J. Johnson Uric acid and cardiovascular risk N. Engl. J. Med. 359 2008 1811 1821
21. G.K. Glantzounis, E.C. Tsimoyiannis, A.M. Kappas, and D.A. Galaris Uric acid and oxidative stress Curr. Pharm. Des. 11 32 2005 4145 4151
22. B.F. Becker Towards the physiological function of uric acid Free Radic. Biol. Med. 14 6 Jun 1993 615 631
23. Y.Y. Sautin, and R.J. Johnson Uric acid: the oxidant-antioxidant paradox Nucleosides Nucleotides Nucleic Acids 27 6 Jun 2008 608 619
24. A. Enomoto, and H. Endou Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease Clin. Exp. Nephrol. 9 3 Sep 2005 195 205
25. S. Amaro, D. Soy, V. Obach, A. Cervera, A.M. Planas, and A. Chamorro Pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischemic stroke Stroke 38 2007 2173 2175
26. W. Duan, B. Ladenheim, R.G. Cutler, I.I. Kruman, J.L. Cadet, and M.P. Mattson Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease J. Neurochem. 80 2002 101 110
27. D.C. Hooper, S. Spitsin, R.B. Kean, and et al. Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis Proc. Natl. Acad. Sci. U. S. A. 95 1998 675 680
28. S.V. Spitsin, G.S. Scott, T. Mikheeva, and et al. Comparison of uric acid and ascorbic acid in protection against EAE Free Radic. Biol. Med. 33 2002 1363 1371
29. A. Chamorro, V. Obach, A. Cervera, M. Revilla, R. Deulofeu, and J.H. Aponte Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke Stroke 33 2002 1048 1052
30. K. Tsukada, T. Hasegawa, S. Tsutsumi, and et al. Effect of uric acid on liver injury during hemorrhagic shock Surgery 127 2000 439 446 (PubMed: 10776436)
31. Sautin YY, and R.J. Johnson Uric acid: the oxidant-antioxidant paradox Nucleosides 27 6 Jun 2008 608 619
32. P. Puddu, G.M. Puddu, E. Cravero, L. Vizioli, and A. Muscari Relationship among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanism and clinical implications J. Cardiol. 59 3 2012 May 235 242
33. W. Imaram, C. Gersch, K.M. Kim, R.J. Johnson, G.N. Henderson, and A. Angerhofer Radicals in the reaction between peroxynitrite and uric acid identified by electron spin resonance spectroscopy and liquid chromatography mass spectrometry Free Radic. Biol. Med. 49 2010 275 281
34. G.L. Squadrito, R. Cueto, A.E. Splenser, and et al. Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid Arch. Biochem. Biophys. 376 2000 333 337
35. J. VasquezVivar, A.M. Santos, V.B.C. Junqueira, and O. Augusto Peroxynitrite-mediated formation of free radicals in human plasma: EPR detection of ascorbyl, albumin-thiyl and uric acid-derived free radicals Biochem. J. 314 1996 869 876
36. C.X.C. Santos, E.I. Anjos, and O. Augusto Uric acid oxidation by peroxynitrite: multiple reactions, free radical formation, and amplification of lipid oxidation Arch. Biochem. Biophys. 372 1999 285 294
37. M. Tomita, S. Mizuno, H. Yamanaka, and et al. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers J. Epidemiol. 10 2000 403e9
38. Y. Gerber, D. Tanne, J.H. Medalie, and et al. Serum uric acid and long-term mortality from stroke, coronary heart disease and all causes Eur. J. Cardiovasc. Prev. Rehabil. 13 2006 193e8
39. C.F. Kuo, L.C. See, K.H. Yu, and et al. Significance of serum uric acid levels on the risk of all cause and cardiovascular mortality Rheumatology (Oxford) 52 2013 127e34
40. S. Takayama, R. Kawamoto, T. Kusunoki, M. Abe, and M. Onji Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome Cardiovasc. Diabetol. 11 2012 2 11
41. G. Levantesi, R.M. Marfisi, M.G. Franzosi, and et al. Uric acid: a cardiovascular risk factor in patients with recent myocardial infarction Int. J. Cardiol. 2012 10.1016/j.ijcard.2011.12.110
42. M.G. Kaya, H. Uyarel, M. Akpek, and et al. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention Am. J. Cardiol. 109 2012 486 491
43. T.G. Von Lueder, N. Girerd, D. Atar, and et al. Highrisk myocardial infarction database initiative investigators. Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the high-risk myocardial infarction database initiative J. Heart Fail. Oct 1 2015 10.1002/ejhf.419
44. G. De Luca, G.G. Secco a, M. Santagostino a, and et al. On behalf of the Novara Atherosclerosis Study Group (NAS).Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study Nutr. Metab. Cardiovasc. Dis. 22 2012 426 433
45. Kivity S, E. Kopel, E. Maor, and et al. Association of serum uric acid and cardiovascular disease in healthy adults Am. J. Cardiol. 111 8 Apr. 15 2013 1146 1151
46. A.G. Stack, A. Hanley, L.F. Casserly, and et al. Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortality Q. J. Med. 106 2013 647 658
47. G. Zhao, L. Huang, and M. Song Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: a meta-analysis of prospective studies Atherosclerosis 231 1 Nov 2013 61 68 Song HYPERLINK "file:///C:/Users/Elio/Desktop/Song%20HYPERLINK%20%22http:/www.ncbi.nlm.nih.gov/pubmed/?term = Song%20Y[Author]&cauthor = true&cauthor-uid = 24125412%22Y"Y
48. P.W. De Leeuw, L. Thijs, W.H. Birkenhager, and et al. Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the SYST-EUR trial J. Am. Soc. Nephrol. 13 2002 2213 2222
49. P. Verdecchia, G. Schillaci, G. Reboldi, F. Santeusanio, C. Porcellati, and P. Brunetti Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the PIUMA study Hypertension 36 2000 1072 1078
50. B.F. Culleton, M.G. Larson, W.B. Kannel, and et al. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study Ann. Intern. Med. 131 1999 7e13
51. K. Sakata, T. Hashimoto, H. Ueshima, and et al. Absence of an association between serum uric acid and mortality from cardiovascular disease: NIPPON DATA 80, 1980e1994. National integrated projects for prospective observation of noncommunicable diseases and its trend in the aged Eur. J. Epidemiol. 17 2001 461e8
52. S.H. Jee, S.Y. Lee, and M.T. Kim Serum uric acid and risk of death from cancer, cardiovascular disease or allcauses in men Eur. J. Cardiovasc. Prev. Rehabil. 11 2004 185e91
53. P. Hu, T.E. Seeman, T.B. Harris, and et al. Is serum uric acid level associated with allcause mortality in high-functioning older persons: MacArthur studies of successful aging? J. Am. Geriatr. Soc. 49 2001 1679e84
54. S.Y. Kim, J.P. Guevara, K.M. Kim, H.K. Choi, D.F. Heitjan, and D.A. Albert Hyperuricemia and coronary heart disease: a systematic review and meta-analysis Arthritis Care Res. 62 2010 170e80
55. S.Y. Kim, J.P. Guevara, K.M. Kim, H.K. Choi, D.F. Heitjan, and D.A. Albert Hyperuricemia and risk of stroke: a systematic review and meta-analysis Arthritis Rheum. 61 7 2009 Jul 15 885 892
56. J.G. Wheeler, K.D. Juzwishin, G. Eiriksdottir, V. Gudnason, and J. Danesh Serum uric acid and coronary heart disease in 9458 incident cases and 155,084 controls: prospective study and meta-analysis PLoS Med. 2 2005 e76
57. T.M. Palmer, B.G. Nordestgaard, M. Benn, and et al. Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisationanalysis of two large cohorts BMJ 347 2013 Jul 18 f4262
58. Savarese G, C. Ferri, B. Trimarco, and et al. Changes in serum uric acid levels and cardiovascular events: a meta-analysis Nutr. Dis. Vol. 23(8) Aug 2013 707 714
59. E.G. Ulf Ekelund, Robert W. Harrison, Ori Shokek, et al. Hare.Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure Circ. Res. 85 1999 437 445
60. S. Baldus, R. Koster, P. Chumley, and et al. Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease Free Radic. Biol. Med. 39 2005 1184 1190
61. U. Landmesser, S. Spiekermann, C. Preuss, and et al. Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease Arterioscler. Thromb. Vasc. Biol. 27 2007 943 948
62. W. Doehner, N. Schoene, M. Rauchhaus, and et al. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flowin hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies Circulation 105 2002
63. C.A. Farquharson, R. Butler, A. Hill, J.J. Belch, and A.D. Struthers Allopurinol improves endothelial dysfunction in chronic heart failure Circulation 106 2002 221 226
64. G.A. Hirsch, P.A. Bottomley, G. Gerstenblith, and R.G. Weiss Allopurinol acutely increases adenosinetriphospate energy delivery in failing human hearts J. Am. 59 9 Feb 28 2012 802 808
65. Thomas P. Cappola, David A. Kass, Gregory S. Nelson, and et al. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy Circulation 104 2001 2407 2411
66. Guthikonda C. Sinkey, T. Barenz, and W.G. Haynes Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers Circulation 107 3 Jan 28 2003 416 421
67. J.M. Hare, B. Mangal, and J. Brown OPT-CHF Investigators Impact ofoxypurinolin patients with symptomatic heart failure. Results of theOPT-CHFstudy J. Am. Coll. Cardiol. 51 24 Jun 17 2008 2301 2309
68. M.M. Givertz, K.J. Anstrom, M.M. Redfield, and et al. NHLBI Heart Failure Clinical Research Network. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study Circulation 131 20 May 19 2015 1763 1771